Slotnik Capital »

Inhibrx Biosciences shares owned by Slotnik Capital

Quarter-by-quarter ownership of Inhibrx Biosciences shares owned by Slotnik Capital from 13F filings

Historical chart of Slotnik Capital investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Slotnik Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Slotnik Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.8M 342k 14.17

More positions owned by Slotnik Capital

Marathon Oil Corporation (MRO)
Hashicorp Com Cl A (HCP)
Hess (HES)
Championx Corp (CHX)
Heartland Financial USA (HTLF)
Catalent (CTLT)
Walkme Ord Shs (WKME)
Silverbow Resources (SBOW)
Capri Holdings Call Call Option
Silk Road Medical Inc Common (SILK)
Axonics Modulation Technolog (AXNX)
Vizio Hldg Corp Cl A Com (VZIO)
Inhibrx Biosciences
Juniper Networks (JNPR)
International Paper Company (IP)

View all positions for Slotnik Capital

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Slotnik Capital
Alpine Associates Management
Millennium Management
TIG Advisors
Morgan Stanley
Ikarian Capital
Geode Capital Management
Caption Management
Marshall Wace
CSS

View all funds holding Inhibrx Biosciences